# Capacity of Amylose Characterisation Compare by Immunohistochemistry and Proteomic Analysis

> **NCT02338427** · NA · COMPLETED · sponsor: **Centre Hospitalier Departemental Vendee** · enrollment: 140 (actual)

## Conditions studied

- Amyloidosis

## Interventions

- **OTHER:** Immunohistochemistry
- **OTHER:** Proteomic analysis

## Key facts

- **NCT ID:** NCT02338427
- **Lead sponsor:** Centre Hospitalier Departemental Vendee
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2018-11
- **Final completion:** 2018-11
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2018-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02338427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02338427, "Capacity of Amylose Characterisation Compare by Immunohistochemistry and Proteomic Analysis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02338427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*